Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study

CONCLUSION: Among AYA cancer patients, a single non-mRNA vaccine dose confers robust hybrid humoral immunity with limited benefit from a second dose.PMID:38514355 | DOI:10.1016/j.vaccine.2024.03.042

Source: Vaccine - March 21, 2024 Category: Allergy & Immunology Authors: Archana Sasi Jyotsna Dandotiya Jyotsana Kaushal Shuvadeep Ganguly Akshay Binayke K M Ambika Akshi Shree Farhana Jahan Priyanka Sharma Tejas Menon Suri Amit Awasthi Sameer Bakhshi Source Type: research